Felix Ricardo, Corzo-Lopez Alejandra, Sandoval Alejandro
Department of Cell Biology, Centre for Research and Advanced Studies (Cinvestav), Mexico City 07360, Mexico.
School of Medicine FES Iztacala, National Autonomous University of Mexico (UNAM), Tlalnepantla 54090, Mexico.
Life (Basel). 2025 May 30;15(6):888. doi: 10.3390/life15060888.
Neuropathic pain is a chronic and debilitating disorder of the somatosensory system that affects a significant proportion of the population and is characterized by abnormal responses such as hyperalgesia and allodynia. Voltage-gated ion channels, including sodium (Na), calcium (Ca), and potassium (K) channels, play a pivotal role in modulating neuronal excitability and pain signal transmission following nerve injury. This review intends to provide a comprehensive analysis of the molecular and cellular mechanisms by which dysregulation in the expression, localization, and function of specific Na channel subtypes (mainly Na1.7 and Na1.8) and their auxiliary subunits contributes to aberrant neuronal activation, the generation of ectopic discharges, and sensitization in neuropathic pain. Likewise, special emphasis is placed on the crucial role of Ca channels, particularly Ca2.2 and the auxiliary subunit Caαδ, whose overexpression increases calcium influx, neurotransmitter release, and neuronal hyperexcitability, thus maintaining persistent pain states. Furthermore, K channels (particularly K7 channels) function as brakes on neuronal excitability, and their dysregulation facilitates the development and maintenance of neuropathic pain. Therefore, targeting specific K channel subtypes to restore their function is also a promising therapeutic strategy for alleviating neuropathic pain symptoms. On the other hand, recent advances in the development of small molecules as selective modulators or inhibitors targeting voltage-gated ion channels are also discussed. These agents have improved efficacy and safety profiles in preclinical and clinical studies by attenuating pathophysiological channel activity and restoring neuronal function. This review seeks to contribute to guiding future research and drug development toward more effective mechanism-based treatments by discussing the molecular mechanisms underlying neuropathic pain and highlighting translational therapeutic opportunities.
神经性疼痛是一种慢性且使人衰弱的躯体感觉系统疾病,影响着相当一部分人群,其特征为痛觉过敏和异常性疼痛等异常反应。电压门控离子通道,包括钠(Na)、钙(Ca)和钾(K)通道,在调节神经损伤后神经元兴奋性和疼痛信号传递方面起着关键作用。本综述旨在全面分析特定钠通道亚型(主要是Na1.7和Na1.8)及其辅助亚基的表达、定位和功能失调导致异常神经元激活、异位放电产生以及神经性疼痛致敏的分子和细胞机制。同样,特别强调钙通道,尤其是Ca2.2及其辅助亚基Caαδ的关键作用,其过度表达会增加钙内流、神经递质释放和神经元过度兴奋,从而维持持续性疼痛状态。此外,钾通道(特别是K7通道)起到抑制神经元兴奋性的作用,其功能失调促进了神经性疼痛的发展和维持。因此,靶向特定钾通道亚型以恢复其功能也是缓解神经性疼痛症状的一种有前景的治疗策略。另一方面,还讨论了作为靶向电压门控离子通道的选择性调节剂或抑制剂的小分子开发的最新进展。这些药物通过减弱病理生理通道活性和恢复神经元功能,在临床前和临床研究中具有更好的疗效和安全性。本综述旨在通过讨论神经性疼痛的分子机制并突出转化治疗机会,为指导未来研究和药物开发朝着更有效的基于机制的治疗方向做出贡献。